Unknown NA INTERVENTIONAL NCT03218059

Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy

Sponsor: Shanghai First Maternity and Infant Hospital

Conditions Cesarean Scar Pregnancy Menstruation

Interventions Methotrexate Combined With Transvaginal Surgery

Updated 6 times since 2017 Last updated: Jul 12, 2017 Started: Jul 15, 2017 Primary completion: Jun 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cesarean Scar Pregnancy and Menstruation, this trial is ongoing. The trial is conducted by Shanghai First Maternity and Infant Hospital and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Aug 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai First Maternity and Infant Hospital

Data source: Shanghai First Maternity and Infant Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China